Replies to post #290080 on NorthWest Biotherapeutics Inc (NWBO)

[hope4patients]

And then read this from the following month:

https://sparktx.com/press_releases/spark-therapeutics-announces-positive-top-line-results-from-pivotal-phase-3-trial-of-spk-rpe65-for-genetic-blinding-conditions/

[hyperopia]

thanks hope4. This part caught my attention:

“The modifications we have made to our final SAP will help create a more robust dataset by increasing the overall amount of information derived from the Phase 3 trial . . . . and believe the steps we have disclosed today will produce an improved data package to support future regulatory filings.”

Hmmmm, a new SAP to support future regulatory filings. Sounds like a pretty good idea.